Pular para o conteúdo
Merck

Congenital sucrase-isomaltase deficiency: identification of a common Inuit founder mutation.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne (2014-12-03)
Julien L Marcadier, Margaret Boland, C Ronald Scott, Kheirie Issa, Zaining Wu, Adam D McIntyre, Robert A Hegele, Michael T Geraghty, Matthew A Lines
RESUMO

Congenital sucrase-isomaltase deficiency is a rare hereditary cause of chronic diarrhea in children. People with this condition lack the intestinal brush-border enzyme required for digestion of di- and oligosaccharides, including sucrose and isomaltose, leading to malabsorption. Although the condition is known to be highly prevalent (about 5%-10%) in several Inuit populations, the genetic basis for this has not been described. We sought to identify a common mutation for congenital sucrase-isomaltase deficiency in the Inuit population. We sequenced the sucrase-isomaltase gene, SI, in a single Inuit proband with congenital sucrase-isomaltase deficiency who had severe fermentative diarrhea and failure to thrive. We then genotyped a further 128 anonymized Inuit controls from a variety of locales in the Canadian Arctic to assess for a possible founder effect. In the proband, we identified a novel, homozygous frameshift mutation, c.273_274delAG (p.Gly92Leufs*8), predicted to result in complete absence of a functional protein product. This change was very common among the Inuit controls, with an observed allele frequency of 17.2% (95% confidence interval [CI] 12.6%-21.8%). The predicted Hardy-Weinberg prevalence of congenital sucrase-isomaltase deficiency in Inuit people, based on this single founder allele, is 3.0% (95% CI 1.4%-4.5%), which is comparable with previous estimates. We found a common mutation, SI c.273_274delAG, to be responsible for the high prevalence of congenital sucrase-isomaltase deficiency among Inuit people. Targeted mutation testing for this allele should afford a simple and minimally invasive means of diagnosing this condition in Inuit patients with chronic diarrhea.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Cloreto de potássio, ACS reagent, 99.0-100.5%
Sigma-Aldrich
Trizma® base, Primary Standard and Buffer, ≥99.9% (titration), crystalline
Sigma-Aldrich
Trizma® base, BioPerformance Certified, meets EP, USP testing specifications, suitable for cell culture, ≥99.9% (titration)
Sigma-Aldrich
Cloreto de magnésio, anhydrous, ≥98%
Sigma-Aldrich
Magnesium chloride solution, for molecular biology, 1.00 M±0.01 M
Sigma-Aldrich
Cloreto de potássio, for molecular biology, ≥99.0%
Sigma-Aldrich
Cloreto de potássio, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E508, 99-100.5% (AT), ≤0.0001% Al
Sigma-Aldrich
Cloreto de potássio, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥99.0%
Sigma-Aldrich
Sigma 7-9®, ≥99% (titration), crystalline
Sigma-Aldrich
Tromethamine, meets USP testing specifications
Sigma-Aldrich
Cloreto de potássio, ReagentPlus®, ≥99.0%
Sigma-Aldrich
Trizma® base, BioUltra, for molecular biology, ≥99.8% (T)
Sigma-Aldrich
Tris(hidroximetil)-aminometano, ACS reagent, ≥99.8%
Sigma-Aldrich
Trizma® base, ≥99.0% (T)
Sigma-Aldrich
Cloreto de potássio, BioUltra, for molecular biology, ~1 M in H2O
Sigma-Aldrich
Cloreto de potássio, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99%
Sigma-Aldrich
Cloreto de magnésio, powder, <200 μm
Sigma-Aldrich
Trizma® base, BioXtra, pH 10.5-12.0 (1 M in H2O), ≥99.9% (titration)
Sigma-Aldrich
Cloreto de potássio, BioUltra, for molecular biology, ≥99.5% (AT)
Sigma-Aldrich
Cloreto de potássio, puriss. p.a., ≥99.5% (AT)
Supelco
Potassium chloride solution, for Ag/AgCl electrodes, ~3 M KCl, saturated with silver chloride
Sigma-Aldrich
Magnesium chloride solution, BioUltra, for molecular biology, 2 M in H2O
Sigma-Aldrich
Trizma® base, ≥99.9% (titration), crystalline
Sigma-Aldrich
Cloreto de magnésio, BioReagent, suitable for insect cell culture, ≥97.0%
Supelco
Cloreto de potássio, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Cloreto de potássio, 99.999% trace metals basis
Sigma-Aldrich
Cloreto de potássio, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99%
Sigma-Aldrich
Cloreto de potássio, BioXtra, ≥99.0%
SAFC
Tromethamine
Sigma-Aldrich
Trizma® base, anhydrous, free-flowing, Redi-Dri, ≥99.9%